"...When GSK signed up to AllTrials Ben Goldacre rolled over and purred. The BMJ featured Andrew Witty on their front cover as the candidate of hope.
Rain on the Parade
In contrast, on this blog, 1boringoldman and on RxISK a small group have warned consistently that this was not good news. That what would be put in place was a mechanism that gave the appearances of transparency but in fact would lock academics into agreeing with GSK and other companies as to what the outcomes of their trials have been.
No one wanted to rain on the AllTrials parade – it never seems like a good idea to fracture a coalition. RxISK put the AllTrials logo on its front page.
Not content with a few academic ghost authors, GSK’s maneuver has put industry well on the way to making Academia a ghost, a glove puppet manipulated by company marketing departments.
Meanwhile Iain Chalmers co-wrote an editorial with GSK endorsing the GSK approach (The Attitude of Chicks to Trojans and Horses) and the British Government produced a document on clinical trial data access that could have been written in GSK central..."
Visit RxISK ORG from Data Based Medicine 'the first free website (not sponsored by big pharma or advertising) for patients and their doctors to research, and more importantly, easily report drug side effects'.